Skip to main content
    M

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $0.64
    +0.01 (+1.43%)

    Market Cap: $26.52M

    Last updated: Nov 17, 2026 at 4:18 PM ET

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a market cap of $26.52M and an enterprise value of $24.01M. Its share count is up 118.01% from a year earlier.

    Total Valuation

    Enterprise value is 9.45% below the market cap, as cash exceeds debt.

    Market Cap$26.52M
    Enterprise Value$24.01M
    Latest price (Nov 17, 2026)$0.64

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateAug 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 66.98% a year over 2 years.

    Shares Outstanding42.02M
    Shares Change (YoY)+118.01%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+66.98%

    Price Statistics

    The stock is down 53.62% over 52 weeks and trades 7.25% below its 50-day average.

    Beta (1Y)1.04
    52-Week Change-53.62%
    1-Month Change-0.33%
    3-Month Change-16.89%
    6-Month Change-32.63%
    Total Return (1Y)-53.62%
    Total Return (3Y CAGR)-42.23%
    Max Drawdown (1Y)-68.23%
    Max Drawdown (3Y)-89.66%
    Sharpe Ratio (1Y)-1.09
    Correlation with SPY (1Y)0.20
    50-Day Average$0.69
    200-Day Average$0.92
    52-Week Range$0.51 to $1.69
    RSI (14 Days)51.5
    Average Volume (20 Days)157.32K

    Price chart

    Financial Position

    Current assets cover 16.97x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio16.97x
    Quick Ratio16.97x
    Debt / Equity0.00x
    Interest Coverage61.00x

    Returns and Efficiency

    Return on equity is -142.73% and return on assets is -134.36% over the last 12 months.

    Return on Equity (ROE)-142.73%
    Return on Assets (ROA)-134.36%
    Return on Capital Employed (ROCE)-141.43%

    Scores

    MIRA has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$9.50M
    Pretax Income-$9.76M
    Net Income-$9.76M
    EBIT-$9.68M
    Reported EPS (TTM)-$0.27

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.09% of the $7.27M in total assets.

    Cash and Equivalents$2.50M
    Total Debt$0
    Net Cash$2.50M
    Net Cash Per Share$0.06
    Working Capital$6.81M
    Shareholder Equity$6.84M
    Book Value Per Share$0.16
    Total Assets$7.27M
    Total Liabilities$426.18K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$4.84M
    FCF Per Share-$0.12

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+21.73%
    Tangible Book Per Share Growth (2Y CAGR)+21.73%

    Revenue and profit by year

    Dividends and Yields

    MIRA does not pay a dividend.

    Buyback Yield-14.26%
    Shareholder Yield-14.26%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MIRA

    What is MIRA's market cap?

    MIRA Pharmaceuticals, Inc. Common Stock has a market cap of $26.52M. Its enterprise value, which adds debt and subtracts cash, is $24.01M.

    How many shares of MIRA are outstanding?

    MIRA Pharmaceuticals, Inc. Common Stock has 42.02M shares outstanding. The count is up 118.01% from a year earlier.

    Does MIRA pay a dividend?

    No. MIRA Pharmaceuticals, Inc. Common Stock does not pay a dividend.

    How much debt does MIRA have?

    MIRA Pharmaceuticals, Inc. Common Stock has $0 of total debt and $2.50M of cash and equivalents, a net cash position of $2.50M.